Pharmaceuticals News and Research

RSS

Combating prescription drug abuse: an interview with Mark Trudeau and Carmen Catizone

Prescription drug abuse is an extremely complex problem with no single solution. For example, the very same medications that are so critical for alleviating pain in legitimate patients could easily be diverted and misused by other people.

16 Sep 2014

Denovo gains all rights from Lilly to develop, manufacture and commercialize enzastaurin drug

Denovo Biopharma, LLC, today announced that it has acquired enzastaurin, a late-stage oncology drug, from Eli Lilly and Company. Denovo gains all rights to develop, manufacture and commercialize enzastaurin globally, including transfer of all intellectual property and other rights, data, and information.

16 Sep 2014

Complete analysis of the global stem cell market

BCC Research reveals in its new report, THE GLOBAL MARKET FOR STEM CELLS, the global market for stem cells is expected to grow to nearly $10.6 billion by 2018, with a five-year compound annual growth rate (CAGR) of 13.6%.

16 Sep 2014

FDA grants Breakthrough Therapy designation to EYLEA Injection for treatment of diabetic retinopathy

Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted EYLEA (aflibercept) Injection Breakthrough Therapy designation for the treatment of diabetic retinopathy in patients with diabetic macular edema (DME).

16 Sep 2014

Pharmaceutical Manufacturing Technology Centre launched in Ireland

The Minister for Skills, Research and Innovation, Damien English TD, today (Friday 12th September 2014) launched the Pharmaceutical Manufacturing Technology Centre (PMTC).

16 Sep 2014

Bayer, Orion begin patient enrollment in ODM-201 Phase III trial for castration-resistant prostate cancer

Bayer HealthCare and Orion Corporation, a pharmaceutical company based in Espoo, Finland, have begun to enroll patients in a Phase III trial with ODM-201, an investigational oral androgen receptor inhibitor in clinical development.

16 Sep 2014

GHIT Fund announces new grants to tackle malaria, chagas disease and dengue

The Global Health Innovative Technology Fund, a new public health partnership that is bringing Japanese know-how and investment to the global fight against infectious diseases, today announced seven grant investments totaling US$15.3 million to speed the development of promising drugs and vaccines to battle three insect-borne diseases-malaria, dengue and Chagas disease.

16 Sep 2014

Complete analysis of the global mHealth market

With more than 7 Billion mobile network subscriptions worldwide, the mobile communications sector is rapidly gaining traction from a diverse range of vertical sectors. Healthcare is no exception to this trend.

15 Sep 2014

Study: High-dose prescribing increases by 23% in Canada

High-dose opioid prescribing increased by 23 per cent in Canada between 2006 and 2011, despite clinical guidelines recommending that most patients should avoid high-doses of these drugs, according to new research.

15 Sep 2014

Multi-purpose swabs available from Qosina

Qosina offers a wide selection of high quality and economical single-use swabs, in addition to its extensive line of single-use components. These products can be used for countless applications in the medical, biological, chemical, pharmaceutical, optical, electronic, industrial, cosmetic, and dermatological industries. Available in a variety of materials, shapes, and sizes, these swabs are ideal for general cleaning, applying or removing product, sample retrieval, and other precision applications.

12 Sep 2014

PwC's HRI releases new report on retail health insurance

PwC's Health Research Institute today released a new report – The Rise of Retail Health Coverage – detailing how retail health insurance marketplaces, known as exchanges, are dramatically changing both the employer benefits environment and the health insurance business.

11 Sep 2014

ChromaDex signs NIAGEN supply agreement with Healthy Directions

ChromaDex Corp., an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, cosmetic and pharmaceutical industries, announced today that it has entered into an ingredient supply agreement with Healthy Directions, a direct-to-consumer nutritional supplement retailer and wholly-owned subsidiary of Helen of Troy Limited.

11 Sep 2014

FDA approves Contrave extended-release tablets for chronic weight management

Takeda Pharmaceuticals U.S.A., Inc. and Orexigen® Therapeutics, Inc. jointly announced today that the U.S. Food and Drug Administration has approved Contrave® extended-release tablets as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index of 30 kg/m2 or greater (obese), or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition.

11 Sep 2014

Cancer Research UK, CRT partner with Asterias to trail novel immunotherapy treatment for lung cancer

CANCER RESEARCH UK and Cancer Research Technology , the charity's development and commercialisation arm, have reached an agreement with Asterias Biotherapeutics, Inc., a biotechnology company in the emerging field of regenerative medicine, to take forward Asterias' novel immunotherapy treatment AST-VAC2 into clinical trials in subjects with non-small cell lung cancer.

11 Sep 2014

Sanofi contributes $2.5 million to CCNA for dementia research

Sanofi announced today its $2.5 million contribution to co-fund the Canadian Consortium on Neurodegeneration in Aging, a partnership officially launched in Montreal today in the presence of The Honourable Rona Ambrose, Minister of Health.

10 Sep 2014

Pharmaceuticals against malaria can now be produced from waste of plant-extraction

Research success through collaborative efforts of chemists and engineers from Berlin/Potsdam and Magdeburg. All of the best currently available pharmaceuticals against malaria can now be produced in pure form using a single process, even from the waste of the plant-extraction.

10 Sep 2014

Young adults use ER less often after health law allowed them to stay on parents' plans

That conclusion is from one study of the expanded coverage. Another study finds young adults don't see themselves as healthier and many still find health care expensive.

10 Sep 2014

National health research forum

Leaders from government, industry, academia and patient advocacy organizations will explore the future of R&D investments, policy trends, public-private partnerships, public health and social sciences research, global health threats and other timely medical and health research issues in panel discussions hosted by Research!America.

9 Sep 2014

Center Director of Omni Eye Surgery describes promising option for managing lid disease

Omni Eye Services, a leading provider of ophthalmologic services at five locations in New York and New Jersey, today announced that Dr. Katherine M Mastrota, Center Director of Omni Eye Surgery in New York City, has written a treatment update for Contact Lenses Today describing a promising "new option for managing lid disease."

9 Sep 2014

Kinex Pharmaceuticals acquires QuaDPharma

Kinex Pharmaceuticals Inc. today announced that it has completed the acquisition of QuaDPharma, LLC., a Western New York based privately-held company specializing in pharmaceutical manufacturing, analytical and support services to the pharmaceutical and biotech industries. Financial terms of the transaction were not disclosed.

9 Sep 2014

Pharmaceuticals News and Research

Combating prescription drug abuse: an interview with Mark Trudeau and Carmen Catizone

Denovo gains all rights from Lilly to develop, manufacture and commercialize enzastaurin drug

Complete analysis of the global stem cell market

FDA grants Breakthrough Therapy designation to EYLEA Injection for treatment of diabetic retinopathy

Pharmaceutical Manufacturing Technology Centre launched in Ireland

Bayer, Orion begin patient enrollment in ODM-201 Phase III trial for castration-resistant prostate cancer

GHIT Fund announces new grants to tackle malaria, chagas disease and dengue

Complete analysis of the global mHealth market

Study: High-dose prescribing increases by 23% in Canada

Multi-purpose swabs available from Qosina

PwC's HRI releases new report on retail health insurance

ChromaDex signs NIAGEN supply agreement with Healthy Directions

FDA approves Contrave extended-release tablets for chronic weight management

Cancer Research UK, CRT partner with Asterias to trail novel immunotherapy treatment for lung cancer

Sanofi contributes $2.5 million to CCNA for dementia research

Pharmaceuticals against malaria can now be produced from waste of plant-extraction

Young adults use ER less often after health law allowed them to stay on parents' plans

National health research forum

Center Director of Omni Eye Surgery describes promising option for managing lid disease

Kinex Pharmaceuticals acquires QuaDPharma

Event guide: 3rd EHS for Biopharma Summit eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Managing vibration in IVF laboratories

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence